These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33345989)

  • 1. Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome.
    Lappen JR; Stark S; Bailit JL; Gibson KS
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100075. PubMed ID: 33345989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery timing for the opioid-exposed infant.
    Sanusi A; Gray M; Xue Y; Mohr S; Curtis P; Dismukes J; Gentle S; Szychowski JM; Brocato B; Casey B; Harper L; Sinkey R
    Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100719. PubMed ID: 35977700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.
    Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.
    Holbrook AM; Jones HE; Heil SH; Martin PR; Stine SM; Fischer G; Coyle MG; Kaltenbach K
    Drug Alcohol Depend; 2013 Sep; 132(1-2):329-34. PubMed ID: 23523131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number of buprenorphine induction attempts impacts maternal and neonatal outcomes: a multicenter cohort study.
    Kelly JC; Ayala NK; Holroyd L; Raghuraman N; Carter EB; Williams SA; Mills MM; Friedman H; Zhang F; Townsel C
    Am J Obstet Gynecol MFM; 2023 Jul; 5(7):100998. PubMed ID: 38236700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes.
    Lund IO; Fischer G; Welle-Strand GK; O'Grady KE; Debelak K; Morrone WR; Jones HE
    Subst Abuse; 2013; 7():61-74. PubMed ID: 23531704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine exposure to maternal opioid maintenance treatment and associated risk factors may impair child growth.
    Kanervo M; Luoto L; Tupola S; Nikkola E; Kahila H; Rantakari K
    Acta Paediatr; 2024 Jul; 113(7):1579-1591. PubMed ID: 38456564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weaning buprenorphine in pregnant patients
    Patel N; O'Brien J; Cockerham C; Hawk G; Parilla B
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2337711. PubMed ID: 38616176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
    Devlin LA; Young LW; Kraft WK; Wachman EM; Czynski A; Merhar SL; Winhusen T; Jones HE; Poindexter BB; Wakschlag LS; Salisbury AL; Matthews AG; Davis JM
    J Perinatol; 2022 Mar; 42(3):300-306. PubMed ID: 34556799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations.
    Suarez EA; Bateman BT; Straub L; Hernández-Díaz S; Jones HE; Gray KJ; Connery HS; Davis JM; Lester B; Terplan M; Zhu Y; Vine SM; Mogun H; Huybrechts KF
    JAMA Intern Med; 2024 Mar; 184(3):242-251. PubMed ID: 38252426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confounding of the Comparative Safety of Prenatal Opioid Agonist Therapy.
    Brogly SB; Hahn KA; Diaz SH; Werler M
    J Addict Res Ther; 2015 Dec; 6(4):. PubMed ID: 27547489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotation from methadone to buprenorphine using a micro-dosing regime in patients with opioid use disorder and serious mental illness: A case series.
    Praeger VC; Frei MY; Pham D; Praeger AJ; Lubman DI; Arunogiri S
    Drug Alcohol Rev; 2024 Jun; ():. PubMed ID: 38894653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.
    Farid WO; Dunlop SA; Tait RJ; Hulse GK
    Curr Neuropharmacol; 2008 Jun; 6(2):125-50. PubMed ID: 19305793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.
    Wouldes TA; Lester BM
    Front Pediatr; 2023; 11():1305508. PubMed ID: 38250592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study.
    Anbalagan S; Anderson V; Favara MT; Stark D; Carola D; Solarin K; Adeniyi-Jones S; Kraft WK; Aghai ZH
    J Perinatol; 2024 Jul; ():. PubMed ID: 39003405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone.
    Elman I; Howard M; Borodovsky JT; Mysels D; Rott D; Borsook D; Albanese M
    Sci Rep; 2020 Mar; 10(1):5617. PubMed ID: 32221389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling.
    van Hoogdalem MW; Tanaka R; Abduljalil K; Johnson TN; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings.
    Noska A; Mohan A; Wakeman S; Rich J; Boutwell A
    J Addict Behav Ther Rehabil; 2015; 4(2):. PubMed ID: 26258153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational buprenorphine-naloxone exposure and fetal neurobehavior.
    Jansson LM; McConnell K; Velez ML; Spencer N; Milio L; Leoutsakos J; DiPietro JA
    Neurotoxicol Teratol; 2024 Jun; 104():107368. PubMed ID: 38906389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prenatal exposure to methadone or buprenorphine and maternal separation on anxiety-like behavior in rats.
    Nyberg H; Bogen IL; Nygaard E; Andersen JM
    Drug Alcohol Depend; 2024 Jun; 262():111367. PubMed ID: 39003831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.